JAMES MCDONOUGH: Open Payments
NPI 1063468700 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 48 payments from 16 companies in 2025. Trend: 2023 $625 · 2024 $1,099 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 5 | $133 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Janssen Pharmaceuticals, Inc | 4 | $81 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Lundbeck LLC | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| Almatica Pharma LLC | 3 | $62 |
| Corium, LLC | 4 | $56 |
Products named: REXULTI, INGREZZA, Auvelity, SPRAVATO, COBENFY, CAPLYTA, Jornay PM, LOREEV XR.
Industry payments across FL — which companies pay providers there.
